Literature DB >> 10656691

Ras protein is involved in the physiological regulation of phospholipase D by platelet derived growth factor.

L Lucas1, L del Peso, P Rodríguez, V Penalva, J C Lacal.   

Abstract

Lipid-derived metabolites play an important role in the regulation of cell responses to external stimuli, including cell growth control, transformation and apoptosis. Phospholipase D (PLD) is one of the critical elements in the regulation of lipid metabolism and the generation of second messengers, some of them involved in cell growth control. Oncogenic Ras proteins affect the activity of PLD by two alternate mechanisms, involving a positive activation and a feedback negative loop. Here we investigate the involvement of the proto-oncogenic Ras protein in the physiological activation of PLD induced by platelet-derived growth factor (PDGF). Over-expression of the wild type Ras protein or some of its regulatory components, such as Shc or Grb2, induces an amplification of PLD activation by PDGF challenge. Furthermore, blocking the endogenous Ras by expression of the dominant negative mutant, H-Ras-Asn17 completely eliminated the activation of PLD by PDGF. Thus, PDGF requires a complex system for PLD regulation implying the existence of at least two positive regulatory pathways, a Ras-dependent and a PKC-dependent mechanism. These results imply that PLD is an important element in signaling by Ras proteins that is altered after ras-induced transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656691     DOI: 10.1038/sj.onc.1203323

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota.

Authors:  J Mwanjewe; M Spitaler; M Ebner; M Windegger; M Geiger; S Kampfer; J Hofmann; F Uberall; H H Grunicke
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

2.  Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.

Authors:  Lizhong Xu; Paul Frankel; Desmond Jackson; Thuy Rotunda; Rita L Boshans; Crislyn D'Souza-Schorey; David A Foster
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2007-10-13       Impact factor: 4.315

Review 4.  Phospholipase D signaling: orchestration by PIP2 and small GTPases.

Authors:  Paschal A Oude Weernink; Maider López de Jesús; Martina Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-24       Impact factor: 3.000

5.  Interaction between RAS gene and lipid metabolism in cancer.

Authors:  Mingquan Zhang; Junchen Pan; Peng Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25

6.  Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.

Authors:  Young-Rae Kim; Hee Sun Byun; Minho Won; Kyeong Ah Park; Jin Man Kim; Byung Lyul Choi; Hyunji Lee; Jang Hee Hong; Jongsun Park; Jeong Ho Seok; Dong Wook Kim; Minho Shong; Seung-Kiel Park; Gang Min Hur
Journal:  BMC Cancer       Date:  2008-05-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.